Navigation Links
China Sky One Medical, Inc. Welcomes Commercial Counselor from Belgium; Looks for Business Alliance with European Companies
Date:5/28/2009

HARBIN, China, May 28 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that Mr. Hubert Cooleman, Flemish economic representative for the North of the PRC and Mongolia, visited Harbin Tian Di Ren Medical Company ("TDR"), a wholly-owned subsidiary of China Sky One, in Harbin on May 26, 2009.

China Sky One management presented and discussed the Company's recent developments with Mr. Cooleman, including its strong product portfolio, its expanded international sales network, and its ongoing research and development projects. In his capacity as economic representative for the North of the PRC, Mr. Cooleman provided suggestions for expanding into Belgium, one of the most advanced countries in the field of biomedical engineering, in order to strengthen ties with the Chinese market.

At the end of the Company's meeting with Mr. Cooleman, a tentative business proposal was reached, which served as a memorandum for the efforts of all parties involved in the discussions. This covered a number of areas, including market entry into both Belgium and China as well as research and development cooperation between both countries. Ms. Xiao-yan Han, Vice Chairman and COO of China Sky One, and Mr. Stanley Hao, CFO of China Sky One, as well as Directors in the international business and research and development departments of the Company, joined the meeting.

"We appreciate Mr. Cooleman's visit to China Sky One and his efforts to help build strong working relationships and a bridge between companies in our two countries," said Ms. Xiao-yan Han, Vice Chairman and COO of China Sky One Medical. "We will continue this dialogue and explore more opportunities in Europe, including international trade and science and technology cooperation opportunities.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com.

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding international cooperation. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    Company Contact:                         Investor Relations Contact:
    China Sky One Medical, Inc.              CCG Investor Relations
    Mr. Stanley Hao, CFO                     Mr. Crocker Coulson, President
    Tel: +86-0451-53994069                   Tel: +1-646-213-1915
    Email: china_sky_one@yahoo.cn             Email: crocker.coulson@ccgir.com
                                             Website: www.ccgirasia.com


'/>"/>
SOURCE China Sky One Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Nepstar Chain Drugstore Reports First Quarter 2009 Financial Results
2. China Nepstar Chain Drugstore Filed 2008 Annual Report on Form 20-F
3. China Kangtai Cactus Biotech Announces Goal to Expand and Enhance Shareholder Communication
4. Frost & Sullivan Looks at the Influence of Chinas New Health Reform on the Pharmaceutical Market
5. NSD Bio Group, LLC Selected By U.S. - China Economic & Security Review Commission for Analysis of Chinas Pharma Supply Chain on U.S. Pharmaceuticals
6. China Medicine Corporation Holds Annual General Meeting of Shareholders
7. China Shenghuo Reports Unaudited Financial Results for the First Quarter of 2009
8. China Medicine Wins Best 1000 SME Award in Guangdong Province; Eligible for RMB 25 Million Loan
9. China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates
10. China and the Netherlands join forces for research into water management
11. China Sky One Medical, Inc. Announces Record First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 2016 , ... In a new paper published in the ... Rod J. Rohrich, and colleagues, examine and underscore the importance of upper lateral ... when addressing this vital area. , The upper lateral cartilage in rhinoplasty, refers ...
(Date:2/11/2016)... Mount Laurel, NJ (PRWEB) , ... February 11, ... ... Commission) announces the call for nominations seeking candidates for the Board of Commissioners. ... individuals with passion, skills and experience with diversity of clinical practice settings and ...
(Date:2/11/2016)... ... February 11, 2016 , ... Life is known for throwing curves. It’s thrown ... who gather once a year to play softball to raise money through Sun ... more than 50 players who competed in this year’s softball tournament share a history ...
(Date:2/11/2016)... ... February 11, 2016 , ... AccuVein Inc. announces the Infusion ... of Practice, to include vascular visualization as a standard practice. AccuVein ( http://www.accuvein.com ... the market, facilitates adherence to this standard with its easy to use, widely ...
(Date:2/11/2016)... ... 11, 2016 , ... Dickinson Insurance & Financial Services continues their commitment to ... support of a local boy named Barrett, who has been fighting ALL leukemia for ... rally support for, all local families dealing with childhood cancer. Information on how to ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Maharashtra, February 12, 2016 ... Market research report titled Chronic Inflammation Global Clinical ... a snapshot of the global clinical trials landscape ... clinical trials by Region, Country (G7 & E7), ... point status and reviews top companies involved and ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
(Date:2/11/2016)... 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial ... 2015. The Company also filed its Quarterly Report on Form ... the Securities and Exchange Commission today. --> ... --> --> Net sales for ... or 95%, to $5.4 million from $2.8 million for the ...
Breaking Medicine Technology: